AAAAAA
Results:
1-9
|
Results: 9
Authors:
Morabito, F
Mangiola, M
Oliva, B
Stelitano, C
Callea, V
Deaglio, S
Iacopino, P
Brugiatelli, M
Malavasi, F
Citation: F. Morabito et al., Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia, LEUK RES, 25(11), 2001, pp. 927-932
Authors:
Palumbo, A
Triolo, S
Baldini, L
Callea, V
Capaldi, A
De Stefano, V
Grasso, M
Liberati, M
Lotesoriere, C
Marceno, R
Marmont, F
Musto, P
Petrucci, MT
Spriano, M
Pileri, A
Boccadoro, M
Citation: A. Palumbo et al., Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients, HAEMATOLOG, 85(5), 2000, pp. 508-513
Authors:
Stelitano, C
Baldini, L
Pieresca, C
Callea, V
Angrilli, F
Clo, V
Partesotti, G
Merli, F
Cavanna, L
Morabito, F
Federico, M
Brugiatelli, M
Silingardi, V
Citation: C. Stelitano et al., Validation of the International Prognostic Index in Working Formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry, HAEMATOLOG, 85(2), 2000, pp. 154-159
Authors:
Callea, V
Stelitano, C
Callea, I
Console, G
Brugiatelli, M
Morabito, F
Citation: V. Callea et al., In vitro drug-induced cytotoxicity predicts clinical response to high-dosechlorambucil in B-cell chronic lymphocytic leukemia, HAEMATOLOG, 84(9), 1999, pp. 863-864
Authors:
Longo, G
Fiorani, C
Sacchi, S
Callea, V
Lombardo, M
Federico, M
Stelitano, C
Angrilli, F
Vallisa, D
Gobbi, PG
Ilariucci, F
Frassoldati, A
Petrini, M
Silingardi, V
Citation: G. Longo et al., Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma, HAEMATOLOG, 84(5), 1999, pp. 425-430
Authors:
Stelitano, C
Morabito, F
Kropp, MG
Callea, V
Iuliano, F
Oriana, V
Levato, D
Nobile, F
Molica, S
Brugiatelli, M
Citation: C. Stelitano et al., Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases, HAEMATOLOG, 84(4), 1999, pp. 317-323
Authors:
Boccadoro, M
Tarella, C
Palumbo, A
Argentino, C
Triolo, S
Dominietto, A
Callea, V
Lauta, VM
Molica, S
Musto, P
Marmont, F
Gianni, AM
Pileri, A
Citation: M. Boccadoro et al., An analysis of which subgroups of multiple myeloma patients, divided according to beta(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy, HAEMATOLOG, 84(10), 1999, pp. 905-910
Authors:
Callea, V
Morabito, F
Oliva, BM
Stelitano, C
Levato, D
Dattilo, A
Gangemi, F
Iorfida, A
Iacopino, P
Nobile, F
Molica, S
Brugiatelli, M
Citation: V. Callea et al., Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is relatedto clinical outcome, BR J HAEM, 107(2), 1999, pp. 347-352
Authors:
Callea, V
Clo, V
Morabito, F
Baldini, L
Stelitano, C
Narni, F
Avanzini, P
Brugiatelli, M
Silingardi, V
Citation: V. Callea et al., Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL), HAEMATOLOG, 83(11), 1998, pp. 993-997
Risultati:
1-9
|